FIGURE 2.

The Kaplan–Meier estimated (A) the overall survival and (B) recurrence‐free survival in patients at modified high risk of recurrence (n = 136) and the subset of these patients for which UISS risk was evaluable and high risk (n = 52). Median overall survival was not estimable and median time to recurrence was estimable only for the UISS high‐risk subgroup (22.0 months). UISS, UCLA Integrated Staging System